Alkermes (ALKS) Net Income towards Common Stockholders (2010 - 2026)
Alkermes (ALKS) reported Net Income towards Common Stockholders of $501,000 for Q2 2026, down 99.4% from $87.1 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alkermes' Net Income towards Common Stockholders came in at $66.12 million, down 81.0% year-over-year; for FY2025, it was $241.66 million, down 34.2% from FY2024.
- By year, Net Income towards Common Stockholders came in at $367.07 million in FY2024 (+3.2%), $355.76 million in FY2023, -$158.27 million in FY2022 and -$48.17 million in FY2021.
- Five-year quarterly Net Income towards Common Stockholders spans a low of -$66.48 million in Q1 2026 and a high of $237.07 million in Q2 2023.
- Year over year, Net Income towards Common Stockholders gained in two of the last seven quarters, with an average decline of 13.8%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q3 2024 (growth of 93.4%); the low point was Q2 2026 (a decline of 99.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$66.48 million (Q1 2026), $49.34 million (Q4 2025) and $82.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Alkermes | 6.99 Bn | 4.13 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 501,000.00 |
| Mar 31, 2026 | -66.48 Mn |
| Dec 31, 2025 | 49.34 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 146.50 Mn |
| Sep 30, 2024 | 92.38 Mn |
| Jun 30, 2024 | 91.36 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 112.78 Mn |
| Sep 30, 2023 | 47.76 Mn |
| Jun 30, 2023 | 237.07 Mn |
| Mar 31, 2023 | -41.85 Mn |
| Dec 31, 2022 | -28.25 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 873,000.00 |
| Sep 30, 2021 | -28.99 Mn |
API Access
Alkermes Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();